The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-05-29

AUTHORS

Paul J Kammermeier

ABSTRACT

BackgroundThe efficacy, potency, and selectivity of the compound 2-Chloro-5-hydroxyphenylglycine (CHPG), a nominally selective agonist for metabotropic glutamate receptor 5 (mGluR5), were examined with select mGluRs by examining their ability to induce modulation of the native voltage dependent ion channels in isolated sympathetic neurons from the rat superior cervical ganglion (SCG). SCG neurons offer a null mGluR-background in which specific mGluR subtypes can be made to express via intranuclear cDNA injection.ResultsConsistent with previous reports, CHPG strongly activated mGluR5b expressed in SCG neurons with an apparent EC50 around 60 μM. Surprisingly, CHPG also activated two mGluR1 splice variants with a similar potency as at mGluR5 when calcium current inhibition was used as an assay for receptor function. No effect of 1 mM CHPG was seen in cells expressing mGluR2 or mGluR4, suggesting that CHPG only activates group I mGluRs (mGluR1 and 5). CHPG was also able to induce modulation of M-type potassium current through mGluR1, but not as consistently as glutamate. Since this channel is modulated through a Gq-dependent pathway, these data indicate that CHPG may exhibit some biased agonist properties on mGluR1. Closer examination of the voltage-independent, Gq-mediated component of mGluR-induced calcium current modulation data confirmed that some biased agonism was evident, but the effect was weak and inconsistent.ConclusionsThese data contrast with the established literature which suggests that CHPG is a selective mGluR5 agonist. Instead, CHPG appears to act equally well as an agonist at mGluR1. While some weak biased agonism was observed with CHPG acting on mGluR1, but not mGluR5, favoring Gi/o signaling over Gq/11, this effect does not appear sufficient to fully explain the discrepancies in the literature. More... »

PAGES

6

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2210-12-6

DOI

http://dx.doi.org/10.1186/1471-2210-12-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043669077

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22642439


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Excitatory Amino Acid Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylacetates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Metabotropic Glutamate 5", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Metabotropic Glutamate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Superior Cervical Ganglion", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Physiology, University of Rochester Medical Center, 14642, Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.412750.5", 
          "name": [
            "Department of Pharmacology and Physiology, University of Rochester Medical Center, 14642, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kammermeier", 
        "givenName": "Paul J", 
        "id": "sg:person.0755324106.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755324106.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrn2867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031073156", 
          "https://doi.org/10.1038/nrn2867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/380255a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044826362", 
          "https://doi.org/10.1038/380255a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/340153a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007550429", 
          "https://doi.org/10.1038/340153a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/283673a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033131130", 
          "https://doi.org/10.1038/283673a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-05-29", 
    "datePublishedReg": "2012-05-29", 
    "description": "BackgroundThe efficacy, potency, and selectivity of the compound 2-Chloro-5-hydroxyphenylglycine (CHPG), a nominally selective agonist for metabotropic glutamate receptor 5 (mGluR5), were examined with select mGluRs by examining their ability to induce modulation of the native voltage dependent ion channels in isolated sympathetic neurons from the rat superior cervical ganglion (SCG). SCG neurons offer a null mGluR-background in which specific mGluR subtypes can be made to express via intranuclear cDNA injection.ResultsConsistent with previous reports, CHPG strongly activated mGluR5b expressed in SCG neurons with an apparent EC50 around 60\u2009\u03bcM. Surprisingly, CHPG also activated two mGluR1 splice variants with a similar potency as at mGluR5 when calcium current inhibition was used as an assay for receptor function. No effect of 1\u2009mM CHPG was seen in cells expressing mGluR2 or mGluR4, suggesting that CHPG only activates group I mGluRs (mGluR1 and 5). CHPG was also able to induce modulation of M-type potassium current through mGluR1, but not as consistently as glutamate. Since this channel is modulated through a Gq-dependent pathway, these data indicate that CHPG may exhibit some biased agonist properties on mGluR1. Closer examination of the voltage-independent, Gq-mediated component of mGluR-induced calcium current modulation data confirmed that some biased agonism was evident, but the effect was weak and inconsistent.ConclusionsThese data contrast with the established literature which suggests that CHPG is a selective mGluR5 agonist. Instead, CHPG appears to act equally well as an agonist at mGluR1. While some weak biased agonism was observed with CHPG acting on mGluR1, but not mGluR5, favoring Gi/o signaling over Gq/11, this effect does not appear sufficient to fully explain the discrepancies in the literature.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2210-12-6", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2521632", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024637", 
        "issn": [
          "1471-2210"
        ], 
        "name": "BMC Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "superior cervical ganglion", 
      "SCG neurons", 
      "M-type potassium current", 
      "biased agonism", 
      "rat superior cervical ganglion", 
      "metabotropic glutamate receptor 5", 
      "calcium current inhibition", 
      "selective mGluR5 agonist", 
      "group I mGluRs", 
      "glutamate receptor 5", 
      "Gi/o", 
      "I mGluRs", 
      "cervical ganglion", 
      "mGluR5 agonist", 
      "sympathetic neurons", 
      "similar efficacy", 
      "mGluR1 splice variants", 
      "agonist 2", 
      "selective agonist", 
      "agonist properties", 
      "receptor 5", 
      "CHPG", 
      "current inhibition", 
      "potassium current", 
      "mGluR1", 
      "Gq-dependent pathway", 
      "cDNA injection", 
      "receptor function", 
      "similar potency", 
      "mGluR5", 
      "apparent EC50", 
      "dependent ion channels", 
      "agonists", 
      "voltage-dependent ion channels", 
      "neurons", 
      "mGluRs", 
      "previous reports", 
      "ion channels", 
      "potency", 
      "efficacy", 
      "agonism", 
      "data contrast", 
      "splice variants", 
      "mGluR2", 
      "mGluR4", 
      "ganglia", 
      "mGluR5b", 
      "subtypes", 
      "modulation", 
      "glutamate", 
      "injection", 
      "EC50", 
      "inhibition", 
      "Gq", 
      "effect", 
      "examination", 
      "ResultsConsistent", 
      "report", 
      "assays", 
      "cells", 
      "pathway", 
      "literature", 
      "data", 
      "variants", 
      "contrast", 
      "function", 
      "ability", 
      "discrepancy", 
      "close examination", 
      "compound 2", 
      "channels", 
      "components", 
      "selectivity", 
      "modulation data", 
      "current", 
      "properties"
    ], 
    "name": "The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency", 
    "pagination": "6", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043669077"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2210-12-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22642439"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2210-12-6", 
      "https://app.dimensions.ai/details/publication/pub.1043669077"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_557.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2210-12-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-6'


 

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      21 PREDICATES      117 URIs      105 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2210-12-6 schema:about N02639f66fc344b18b517495175bca519
2 N070d15fa59ed4bedb08dc95a42b5bcdb
3 N0ff9ff579cee4c0b97e1b6dc686d8942
4 N4fd4664c0e744a51bd292709e5cf16b1
5 N6ef81671272448d581d0491f0c10a8ce
6 N75365593501f40c8a8fc39de6b15eb77
7 N7761095911184a919815ff914abd5b52
8 N7bc372a153704c1390666a7ed30f4857
9 N80e4540f61bb4accb06c5fe69d1b2421
10 Nba0134dbb9fb4f33b5e9efdf43b46ce6
11 Nca86a211b0944f81957a3fa0c54beeb8
12 Nf4b3d3e619274c879bbdbed962004cd5
13 anzsrc-for:11
14 anzsrc-for:1109
15 schema:author Nc7aa553e2e1a4a95bca8e0124b44737d
16 schema:citation sg:pub.10.1038/283673a0
17 sg:pub.10.1038/340153a0
18 sg:pub.10.1038/380255a0
19 sg:pub.10.1038/nrn2867
20 schema:datePublished 2012-05-29
21 schema:datePublishedReg 2012-05-29
22 schema:description BackgroundThe efficacy, potency, and selectivity of the compound 2-Chloro-5-hydroxyphenylglycine (CHPG), a nominally selective agonist for metabotropic glutamate receptor 5 (mGluR5), were examined with select mGluRs by examining their ability to induce modulation of the native voltage dependent ion channels in isolated sympathetic neurons from the rat superior cervical ganglion (SCG). SCG neurons offer a null mGluR-background in which specific mGluR subtypes can be made to express via intranuclear cDNA injection.ResultsConsistent with previous reports, CHPG strongly activated mGluR5b expressed in SCG neurons with an apparent EC50 around 60 μM. Surprisingly, CHPG also activated two mGluR1 splice variants with a similar potency as at mGluR5 when calcium current inhibition was used as an assay for receptor function. No effect of 1 mM CHPG was seen in cells expressing mGluR2 or mGluR4, suggesting that CHPG only activates group I mGluRs (mGluR1 and 5). CHPG was also able to induce modulation of M-type potassium current through mGluR1, but not as consistently as glutamate. Since this channel is modulated through a Gq-dependent pathway, these data indicate that CHPG may exhibit some biased agonist properties on mGluR1. Closer examination of the voltage-independent, Gq-mediated component of mGluR-induced calcium current modulation data confirmed that some biased agonism was evident, but the effect was weak and inconsistent.ConclusionsThese data contrast with the established literature which suggests that CHPG is a selective mGluR5 agonist. Instead, CHPG appears to act equally well as an agonist at mGluR1. While some weak biased agonism was observed with CHPG acting on mGluR1, but not mGluR5, favoring Gi/o signaling over Gq/11, this effect does not appear sufficient to fully explain the discrepancies in the literature.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N2504adc9dcf549dd9ca3822ab1b37e0f
26 N44e10742207b4fd688ca8f86cfe6c7a6
27 sg:journal.1024637
28 schema:keywords CHPG
29 EC50
30 Gi/o
31 Gq
32 Gq-dependent pathway
33 I mGluRs
34 M-type potassium current
35 ResultsConsistent
36 SCG neurons
37 ability
38 agonism
39 agonist 2
40 agonist properties
41 agonists
42 apparent EC50
43 assays
44 biased agonism
45 cDNA injection
46 calcium current inhibition
47 cells
48 cervical ganglion
49 channels
50 close examination
51 components
52 compound 2
53 contrast
54 current
55 current inhibition
56 data
57 data contrast
58 dependent ion channels
59 discrepancy
60 effect
61 efficacy
62 examination
63 function
64 ganglia
65 glutamate
66 glutamate receptor 5
67 group I mGluRs
68 inhibition
69 injection
70 ion channels
71 literature
72 mGluR1
73 mGluR1 splice variants
74 mGluR2
75 mGluR4
76 mGluR5
77 mGluR5 agonist
78 mGluR5b
79 mGluRs
80 metabotropic glutamate receptor 5
81 modulation
82 modulation data
83 neurons
84 pathway
85 potassium current
86 potency
87 previous reports
88 properties
89 rat superior cervical ganglion
90 receptor 5
91 receptor function
92 report
93 selective agonist
94 selective mGluR5 agonist
95 selectivity
96 similar efficacy
97 similar potency
98 splice variants
99 subtypes
100 superior cervical ganglion
101 sympathetic neurons
102 variants
103 voltage-dependent ion channels
104 schema:name The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency
105 schema:pagination 6
106 schema:productId N18e1b170886741918af91322b79c4011
107 N1b96a7c66cf846cfa2cba1c6e7f52ffe
108 Nf63c220ca84e4b1a813c13fd016f18fb
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043669077
110 https://doi.org/10.1186/1471-2210-12-6
111 schema:sdDatePublished 2022-12-01T06:29
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Ndabb77182f4e445e96983a6ed61243ce
114 schema:url https://doi.org/10.1186/1471-2210-12-6
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N02639f66fc344b18b517495175bca519 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Receptors, Metabotropic Glutamate
120 rdf:type schema:DefinedTerm
121 N070d15fa59ed4bedb08dc95a42b5bcdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Calcium
123 rdf:type schema:DefinedTerm
124 N0ff9ff579cee4c0b97e1b6dc686d8942 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Phenylacetates
126 rdf:type schema:DefinedTerm
127 N18e1b170886741918af91322b79c4011 schema:name dimensions_id
128 schema:value pub.1043669077
129 rdf:type schema:PropertyValue
130 N1b96a7c66cf846cfa2cba1c6e7f52ffe schema:name doi
131 schema:value 10.1186/1471-2210-12-6
132 rdf:type schema:PropertyValue
133 N2504adc9dcf549dd9ca3822ab1b37e0f schema:volumeNumber 12
134 rdf:type schema:PublicationVolume
135 N44e10742207b4fd688ca8f86cfe6c7a6 schema:issueNumber 1
136 rdf:type schema:PublicationIssue
137 N4fd4664c0e744a51bd292709e5cf16b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Receptor, Metabotropic Glutamate 5
139 rdf:type schema:DefinedTerm
140 N6ef81671272448d581d0491f0c10a8ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Neurons
142 rdf:type schema:DefinedTerm
143 N75365593501f40c8a8fc39de6b15eb77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Male
145 rdf:type schema:DefinedTerm
146 N7761095911184a919815ff914abd5b52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Superior Cervical Ganglion
148 rdf:type schema:DefinedTerm
149 N7bc372a153704c1390666a7ed30f4857 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Rats, Wistar
151 rdf:type schema:DefinedTerm
152 N80e4540f61bb4accb06c5fe69d1b2421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Rats
154 rdf:type schema:DefinedTerm
155 Nba0134dbb9fb4f33b5e9efdf43b46ce6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Animals
157 rdf:type schema:DefinedTerm
158 Nc7aa553e2e1a4a95bca8e0124b44737d rdf:first sg:person.0755324106.83
159 rdf:rest rdf:nil
160 Nca86a211b0944f81957a3fa0c54beeb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Glycine
162 rdf:type schema:DefinedTerm
163 Ndabb77182f4e445e96983a6ed61243ce schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nf4b3d3e619274c879bbdbed962004cd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Excitatory Amino Acid Agonists
167 rdf:type schema:DefinedTerm
168 Nf63c220ca84e4b1a813c13fd016f18fb schema:name pubmed_id
169 schema:value 22642439
170 rdf:type schema:PropertyValue
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
175 schema:name Neurosciences
176 rdf:type schema:DefinedTerm
177 sg:grant.2521632 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2210-12-6
178 rdf:type schema:MonetaryGrant
179 sg:journal.1024637 schema:issn 1471-2210
180 schema:name BMC Pharmacology
181 schema:publisher Springer Nature
182 rdf:type schema:Periodical
183 sg:person.0755324106.83 schema:affiliation grid-institutes:grid.412750.5
184 schema:familyName Kammermeier
185 schema:givenName Paul J
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755324106.83
187 rdf:type schema:Person
188 sg:pub.10.1038/283673a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033131130
189 https://doi.org/10.1038/283673a0
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/340153a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007550429
192 https://doi.org/10.1038/340153a0
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/380255a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044826362
195 https://doi.org/10.1038/380255a0
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/nrn2867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031073156
198 https://doi.org/10.1038/nrn2867
199 rdf:type schema:CreativeWork
200 grid-institutes:grid.412750.5 schema:alternateName Department of Pharmacology and Physiology, University of Rochester Medical Center, 14642, Rochester, NY, USA
201 schema:name Department of Pharmacology and Physiology, University of Rochester Medical Center, 14642, Rochester, NY, USA
202 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...